amiea med

What amiea med does

amiea med is the medical aesthetics brand of MT.DERM GmbH, a family-owned private limited company incorporated in Berlin, Germany (HRB 70730) with copyright dating to 2011. The company designs, develops, and manufactures medical microneedling devices for percutaneous collagen induction (PCI), serving dermatologists, plastic surgeons, aesthetic physicians, and licensed skincare therapists in regulated global markets. The flagship EXCEED device is FDA 510(k)-cleared (K180778 for facial wrinkles; K182407 for facial acne scars) and EU MDR-certified, and is produced in a 5,200 m² ISO 13485-certified cleanroom facility in Berlin with CNC machines and specialized manufacturing automation.

The product platform centers on the EXCEED hardware device (power unit, cable-connected handpiece, footswitch, adjustable needle speed 100-150 Hz, depth 0-1.9 mm) paired with a disposable safety cartridge consumable protected by a patented safety membrane that prevents liquid backflow contamination. The portfolio is rounded out with accessories (device stand, hygiene sleeves) and a cosmetics line (Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, Face Relief Mask) designed to enhance and prolong post-treatment outcomes. R&D staff are sourced from the Technical University of Berlin, and the company holds TÜV SÜD certification partner status.

Revenue mechanics combine capital equipment sales (EXCEED device) with a recurring cartridge consumable annuity and accessories/cosmetics uplift. Go-to-market is executed through authorized retailers globally, supplemented by direct consultation inquiries, an Education Hub for practitioner training and certification, clinical-evidence marketing referencing peer-reviewed outcomes (78% periorbital wrinkle reduction in 90 days, 90% facial wrinkle improvement, 86% acne scar improvement), and event partnerships with industry bodies including IMCAS and DGPraec. Public pricing is not disclosed; the company operates contact-based B2B sales with placeholder pricing on its website.

Name

amiea med

Legal name

MT.DERM GmbH

Website

https://amieamed.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

amiea med, a brand of Berlin-based MT.DERM GmbH, designs and manufactures FDA-cleared and EU MDR-certified medical microneedling devices (EXCEED) and disposable safety cartridges for dermatologists, plastic surgeons, and licensed skincare therapists globally.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Toilet Preparation Manufacturing (32562)

SIC

Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Microneedling / Collagen Induction Therapy (HSALADAI)

akta.pro secondary industries

Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI), Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

Keywords

• Medical microneedling devices
• Percutaneous collagen induction
• Aesthetic medical equipment
• Clinical skincare devices
• Medical device manufacturing

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Microneedling Devices: Sale of EXCEED device — a cutting-edge, clinically proven microneedling device sold as a classic device with power unit, cable connected handpiece, and footswitch. Primary capital equipment revenue.
2. Safety Cartridges: Disposable hygienic needle cartridges for the EXCEED device. Patented safety membrane prevents contamination. Recurring consumable revenue from repeat purchases by practitioners.
3. Accessories: EXCEED device stand (for stability and workflow optimization) and hygiene sleeves (protecting against contamination from bodily fluids). Ancillary product revenue.
4. Cosmetics: Skincare product line including Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, and Face Relief Mask. Sold as adjunct products to enhance and prolong microneedling treatment results.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

amiea med designs, develops, and manufactures the EXCEED medical microneedling device and supporting product line for medical aesthetics professionals. The offering comprises the EXCEED device (power unit, handpiece, footswitch), disposable hygienic safety cartridges with patented membrane, accessories (device stand, hygiene sleeves), and a complementary cosmetics line formulated for post-microneedling skin treatment. All devices are produced in ISO 13485-certified cleanroom facilities in Berlin, Germany.

Product overview

Amiea med is a brand of MT.DERM GmbH that manufactures medical microneedling devices and skincare products. The product portfolio centers on the EXCEED microneedling device (the core platform), supported by disposable safety cartridges and accessories (device stand, hygiene sleeves), and complemented by a cosmetics line (Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, Face Relief Mask) designed to enhance microneedling treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• EXCEED Medical Microneedling Device FDA-cleared and MDR-certified medical microneedling device for treating facial acne scars and wrinkles in adult patients. Features adjustable needle speed (100-150 Hz), adjustable needle length (0-1.9 mm), cable-connected handpiece, power unit, and footswitch. Sold to medical aesthetics professionals including dermatologists, plastic surgeons, and aesthetic physicians.
• EXCEED Safety Cartridges Disposable hygienic cartridge system with patented safety membrane that prevents liquid backflow and contamination to the handpiece. Features a 6-point needle plate with 1.5 mm needle length and tilting needle plate for perpendicular skin penetration. Sold as a recurring-use consumable to EXCEED device owners.
• EXCEED Accessories Ancillary products for the EXCEED device including a device stand for stability and workflow convenience, and hygiene sleeves that protect against contamination from bodily fluids during treatment.
• Amiea Med Cosmetics Line Skincare products designed to enhance microneedling treatments, including Bare Skin Cleanser, Cell Activator Serum, Skin Repair Moisturiser, and Face Relief Mask (biocellulose sheet mask). Sold as adjunct products to practitioners and end users to improve absorption of active ingredients and reduce inflammation post-treatment.

Quantifiable outcome

• 78% of patients experienced a remarkable reduction in periorbital wrinkles in just 90 days
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Remy&RemyminorImplementation/ SI/ Consulting PartnerRemy&Remy is credited as the website developer for the amiiea med website. This is a vendor/agency relationship for website design and development services.
• TÜV SÜDcoreStrategic or Co-development PartnerTÜV SÜD is shown as a certification partner on the amiiea med website, indicating compliance certification for quality and safety standards in medical device manufacturing.
• DGPraec (Deutsche Gesellschaft für Ästhetische Botulinumtoxin-Therapie)minorGTM or Marketing PartnerDGPraec (German Society for Aesthetic Botulinumtoxin Therapy) is listed as an event partner, with their logo displayed on the events page.
• IMCAS (International Master Course on Aging Science)minorGTM or Marketing PartnerIMCAS is listed as an event partner for IMCAS World 2027, with their logo displayed on the events page. IMCAS is a global educational organization for plastic surgery and dermatology.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• EndyMed Medical: EndyMed offers Intensif, a microneedling/RF platform targeting acne scars and skin rejuvenation indications overlapping with EXCEED. It is smaller and more regionally focused than InMode or Cutera but directly competes for the same clinical use cases.

Regional players

• Aesthetic Management Partners: Aesthetic Management Partners distributes aesthetic devices including microneedling systems to US practices, comparable in go-to-market motion (authorized-reseller distribution) to amiea med's US strategy. It represents a regional channel-side peer rather than a device-architecture competitor.

Direct peers

• Dermapen World: Dermapen World manufactures Dermapen 4, a leading global microneedling device brand with a strong practitioner following and proprietary needle cartridge system. It competes head-to-head with EXCEED in clinics and med-spas across both the EU and US.
• Eclipse MedCorp (MicroPen Evo): Eclipse's MicroPen Evo is a cordless, automated microneedling device widely used in dermatology and aesthetic practices. It is a direct alternative to EXCEED with similar clinical indications, treatment depth ranges, and cartridge-based recurring revenue.
• Crown Aesthetics (SkinPen): Crown Aesthetics markets SkinPen, the first FDA-cleared microneedling device in the US, directly competing with EXCEED in dermatology and plastic surgery practices. Both target the same clinical indications (acne scars, wrinkles) with a similar razor-and-blade cartridge model and comparable price points.

Broad incumbents

• Candela (Gentle Pro / Vbeam / Matrix): Candela is a global medical aesthetics incumbent offering laser and energy-based devices for skin rejuvenation indications that compete with EXCEED for practice capex budgets. Its broader portfolio and large global sales force make it a broader-scope competitor.
• InMode (Morpheus8): InMode's Morpheus8 is a leading RF-microneedling platform combining fractional radiofrequency with microneedling, competing with EXCEED for the same patient indications and practice budgets. InMode is a broader, publicly listed aesthetics incumbent with significantly larger sales and marketing scale.
• Sinclair Pharma (MaiLi / Perfectha): Sinclair Pharma is an aesthetics company with a portfolio of injectable and skin-quality products overlapping with the patient journey that drives EXCEED demand. While not a direct microneedling competitor, it is a strategic consolidator-type adjacent in the professional aesthetics channel.
• Venus Concept (Venus Viva / Venus Versa): Venus Concept markets microneedling and RF-microneedling solutions aimed at medical aesthetics practices. It competes with EXCEED across rejuvenation and acne-scar use cases and operates a global aesthetics sales infrastructure.
• Cutera (Secret RF / VirtueRF): Cutera markets Secret RF and VirtueRF, RF-microneedling devices that compete with EXCEED on acne scars and rejuvenation indications. As a publicly listed aesthetics platform, Cutera offers broader portfolios and a larger US sales infrastructure than amiea med.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/amiea-med

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about amiea med